Institutional Trading Of Deciphera Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Institutional trading of deciphera pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Institutional Trading Of Deciphera Pharmaceuticals Today - Breaking & Trending Today

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 12-Month High at $25.59

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $25.59 and last traded at $25.58, with a volume of 366347 shares changing hands. The stock had previously closed at $25.57. Analysts Set New Price Targets A number of […] ....

United States , Charles Schwab Investment Management Inc , Deciphera Pharmaceuticals Price Performance , Institutional Trading Of Deciphera Pharmaceuticals , Deciphera Pharmaceuticals , Deciphera Pharmaceuticals Inc , Principal Financial Group Inc , Jefferies Financial Group , Deciphera Pharmaceuticals Company Profile , Deutsche Bank , Jpmorgan Chase Co , News Ratings For Deciphera Pharmaceuticals Daily , Get Free Report , Financial Group , Schwab Investment Management , Investment Management , Dark Forest Capital Management , Forest Capital Management , Deciphera Pharmaceuticals Daily ,

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives $24.17 Average Price Target from Brokerages

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) have been assigned a consensus recommendation of “Hold” from the ten brokerages that are currently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month […] ....

United States , Deciphera Pharmaceuticals Inc , Deciphera Pharmaceuticals Stock Performance , Deciphera Pharmaceuticals , Institutional Trading Of Deciphera Pharmaceuticals , News Ratings For Deciphera Pharmaceuticals Daily , Deutsche Bank , Deciphera Pharmaceuticals Company Profile , Analyst Recommendations For Deciphera Pharmaceuticals , Deerfield Management Companylp Series , Jpmorgan Chase Co , Fisher Asset Management , Get Free Report , Asset Management , Forest Capital Management , Trexquant Investment , Get Free , Deciphera Pharmaceuticals Daily ,

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives $23.87 Consensus PT from Analysts

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives $23.87 Consensus PT from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Stifel Nicolaus , Deciphera Pharmaceuticals Stock Performance , Deciphera Pharmaceuticals , Dimensional Fund Advisors , Jpmorgan Chase Co , Deerfield Management Companylp Series , Analyst Recommendations For Deciphera Pharmaceuticals , Institutional Trading Of Deciphera Pharmaceuticals , Goldman Sachs Group Inc , News Ratings For Deciphera Pharmaceuticals Daily , Deciphera Pharmaceuticals Inc , Armistice Capital , Frazier Life Sciences Management , Get Free Report , Sachs Group , Fund Advisors , Get Free , Deciphera Pharmaceuticals Daily ,

Deciphera Pharmaceuticals (NASDAQ:DCPH) Lifted to Equal Weight at Barclays

Deciphera Pharmaceuticals (NASDAQ:DCPH) Lifted to Equal Weight at Barclays
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Stifel Nicolaus , Analyst Recommendations For Deciphera Pharmaceuticals , Exchange Traded Concepts , Deciphera Pharmaceuticals Inc , Deciphera Pharmaceuticals , Institutional Trading Of Deciphera Pharmaceuticals , Quest Partners , Jefferies Financial Group , China Universal Asset Management Co , News Ratings For Deciphera Pharmaceuticals Daily , Jpmorgan Chase Co , Deciphera Pharmaceuticals Price Performance , Free Report , Financial Group , Get Free Report , Universal Asset Management , Traded Concepts , Aigen Investment Management , Deciphera Pharmaceuticals Daily ,

Deciphera Pharmaceuticals (NASDAQ:DCPH) Earns "Hold" Rating from Jefferies Financial Group

Jefferies Financial Group restated their hold rating on shares of Deciphera Pharmaceuticals (NASDAQ:DCPH – Free Report) in a report released on Monday, Benzinga reports. Jefferies Financial Group currently has a $25.60 price target on the stock, down from their prior price target of $26.00. DCPH has been the topic of several other research reports. Jonestrading […] ....

United States , Stifel Nicolaus , Deciphera Pharmaceuticals Inc , Jefferies Financial Group , Deciphera Pharmaceuticals , Institutional Trading Of Deciphera Pharmaceuticals , Deciphera Pharmaceuticals Price Performance , News Ratings For Deciphera Pharmaceuticals Daily , Exchange Traded Concepts , China Universal Asset Management Co , Jpmorgan Chase Co , Quest Partners , Analyst Recommendations For Deciphera Pharmaceuticals , Free Report , Financial Group , Get Free Report , Universal Asset Management , Traded Concepts , Aigen Investment Management , Deciphera Pharmaceuticals Daily , Nasdaq Dcph , Reiterated Rating , Jefferies Financial Group Inc ,